Stay updated on Nicotinamide Riboside in Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Nicotinamide Riboside in Heart Failure Clinical Trial page.

Latest updates to the Nicotinamide Riboside in Heart Failure Clinical Trial page
- Check3 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been changed from June 2025 to July 2025.SummaryDifference0.5%
- Check17 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check24 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check31 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.8%
- Check67 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check74 days agoChange DetectedThe page has undergone a significant revision, changing from version v2.14.4 to v2.15.0, and has removed key collaborator information including the Principal Investigator's name and associated grant details.SummaryDifference0.9%
Stay in the know with updates to Nicotinamide Riboside in Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nicotinamide Riboside in Heart Failure Clinical Trial page.